Spain / Pharma News Roundup September 2020
A roundup of the latest news from Spanish pharma, including J&J’s COVID-19 vaccine trial, the latest developments at Spanish firm PharmaMar which hopes its Aplidin can be used as a…
The Royal Academy of Medicine began its history in the first third of the eighteenth century in the midst of a gathering in the pharmacy of José Hortega, under the Enlightenment movement. In July 1733 it became a grouping of professionals, initially titled “Tertulia Médico-Chymica-Phisica” and later “Tertulia Médica Matritense”.
It received the royal sanction from Felipe V in September 18, 1734, following approval of its statutes, which became the Tertulia in Academia.
It was reorganized by Royal Decree of April 28, 1861, “to promote the progress of Spanish medicine, publish its story literature, forming the medical geography and a technological dictionary of medicine.”
It uses as emblem a shield that represents the allegory of Archimedes, which states that by using many small mirrors arranged in a dish and using the sun’s rays, set the Roman fleet on fire.
The academic medals bear a midwife allegory symbolizing medicine and the legend “Ars cum natura ad salutem conspirans”.
Today, the Royal Academy of Medicine holds public scientific sessions every Tuesday during the course, in which two scholars set scientific issues, takeover sessions, opening and closing of the course, special sessions, etc.
Regarding publications, the journal published quarterly RANM Annals, which includes the lectures delivered at scientific sessions, news bulletins, an activity newsletter and monographs, etc…
The tasks and current projects of the Royal Academy include: the Dictionary of Medical Terms, the announcement and awarding of prizes, computerization of its bibliography, etc.
It consists of fifty Academic Fellows and Honor Scholars, Corresponding National and Foreign Fees and Medals of Honor.
Its current President, since 2012, is Prof. D. Joaquin Poch Broto.
CONTACT DETAILS
Calle Arrieta nº12
28013 Madrid
Tlf.: +34 91 547 03 18
Fax: +34 91 547 03 20
A roundup of the latest news from Spanish pharma, including J&J’s COVID-19 vaccine trial, the latest developments at Spanish firm PharmaMar which hopes its Aplidin can be used as a…
PharmaMar, a Spanish firm, is beginning Phase II clinical trials for its anti-tumour drug Aplidin to treat coronavirus. The firm’s stocks have soared on the news. PharmaMar is joining…
Building on the topics covered in our March 2019 report, the latest edition of Healthcare & Life Sciences Review Spain takes a closer look at the broader Spanish life sciences…
Juan Carlos Moro Rodríguez, CEO for the Iberia Cluster with DB Schenker, discusses the company’s plans to expand its reach across all forms of transport, offering logistics solutions rather than…
Though still one of the younger and lesser-known outfits inhabiting the European drug development landscape, Irish-headquartered rare disease specialist, Jazz pharma has been making tremendous headway in the onco-haematology and…
In what is a highly competitive and crowded women’s health field in Spain, smaller players are having to be increasingly focused and specialised to carve out a market share. …
Many of the world’s mega-rich are increasingly active philanthropists in the healthcare arena and Spain is no exception with Galician billionaire Amancio Ortega Gaona, the 82-year-old owner of clothing empire…
The global acquisition of GSK’s thrombosis portfolio and subsequent purchase of AstraZeneca’s anaesthesia business have been critical milestones for the maverick South African pharmaceutical outfit Aspen, enabling the company to…
Perhaps the only CEO of a dermo-cosmetics company with a PhD in astrophysics and space technology as well as three years working at NASA under his belt, Isdin’s Juan Naya…
The North-Eastern region of Catalonia is one of Spain’s most prosperous and has been allocating increasingly large amounts of its budget towards healthcare. With strong government backing and a robust…
Rocco De Bernardis, managing director for Johnson & Johnson Medical Devices in Spain offers his insights into the company’s local footprint, assesses the situation for value-based healthcare implementation in Spain…
Through a merger between INC Research and inVentiv Health in 2018, Syneos Health has become the industry’s only fully integrated biopharmaceutical solutions organisation which includes one of the world’s top…
See our Cookie Privacy Policy Here